Livmarli
Payments companies reported to CMS as associated with Livmarli. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Livmarli, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Livmarli
These are the largest totals companies reported as associated with Livmarli. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jennifer Vittorio | New York, NY | Pediatric Transplant Hepatology | $144,652.08 |
| Alisha Mavis | Charlotte, NC | Pediatric Transplant Hepatology | $138,582.23 |
| William Balistreri | Cincinnati, OH | Pediatric Gastroenterology | $115,126.35 |
| Saeed Mohammad | Nashville, TN | Pediatric Transplant Hepatology | $111,431.95 |
| Binita Kamath Patel | Philadelphia, PA | Pediatrics | $76,004.66 |
| Lee Bass | Chicago, IL | Pediatric Gastroenterology | $67,841.65 |
| Regino Gonzalez-Peralta | Orlando, FL | Pediatric Gastroenterology | $66,313.80 |
| Robert Venick | Los Angeles, CA | Pediatric Gastroenterology | $53,962.34 |
| Paul Watkins | Chapel Hill, NC | Gastroenterology (Internal Medicine) | $50,212.50 |
| Shari Sheflin Findling | New Hyde Park, NY | Pediatric Gastroenterology | $49,558.85 |
Prescribed Livmarli?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.